-DOCSTART- -X- O
We -X- _ O
studied -X- _ O
the -X- _ O
viral -X- _ B-Intervention
etiology -X- _ I-Intervention
of -X- _ O
acute -X- _ B-Patient
expiratory -X- _ I-Patient
wheezing -X- _ I-Patient
( -X- _ I-Patient
bronchiolitis -X- _ I-Patient
, -X- _ I-Patient
acute -X- _ I-Patient
asthma -X- _ I-Patient
) -X- _ I-Patient
in -X- _ I-Patient
293 -X- _ I-Patient
hospitalized -X- _ I-Patient
children -X- _ I-Patient
in -X- _ O
a -X- _ O
2-year -X- _ O
prospective -X- _ O
study -X- _ O
in -X- _ O
Finland. -X- _ O
A -X- _ O
potential -X- _ B-Outcome
causative -X- _ I-Outcome
viral -X- _ I-Outcome
agent -X- _ I-Outcome
was -X- _ I-Outcome
detected -X- _ I-Outcome
in -X- _ I-Outcome
88 -X- _ I-Outcome
% -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
cases. -X- _ I-Outcome
Eleven -X- _ O
different -X- _ O
viruses -X- _ O
were -X- _ O
represented. -X- _ O
Respiratory -X- _ B-Outcome
syncytial -X- _ I-Outcome
virus -X- _ I-Outcome
( -X- _ I-Outcome
RSV -X- _ I-Outcome
) -X- _ I-Outcome
( -X- _ I-Outcome
27 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
enteroviruses -X- _ I-Outcome
( -X- _ I-Outcome
25 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
rhinovirus -X- _ I-Outcome
( -X- _ I-Outcome
24 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
nontypable -X- _ I-Outcome
rhino -X- _ I-Outcome
/ -X- _ I-Outcome
enterovirus -X- _ I-Outcome
( -X- _ I-Outcome
16 -X- _ I-Outcome
% -X- _ I-Outcome
) -X- _ I-Outcome
were -X- _ I-Outcome
found -X- _ I-Outcome
most -X- _ I-Outcome
frequently. -X- _ I-Outcome
In -X- _ I-Outcome
infants -X- _ I-Outcome
, -X- _ I-Outcome
RSV -X- _ I-Outcome
was -X- _ I-Outcome
found -X- _ I-Outcome
in -X- _ I-Outcome
54 -X- _ I-Outcome
% -X- _ I-Outcome
and -X- _ I-Outcome
respiratory -X- _ I-Outcome
picornaviruses -X- _ I-Outcome
( -X- _ I-Outcome
rhinovirus -X- _ I-Outcome
and -X- _ I-Outcome
enteroviruses -X- _ I-Outcome
) -X- _ I-Outcome
in -X- _ I-Outcome
42 -X- _ I-Outcome
% -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
cases. -X- _ I-Outcome
In -X- _ I-Outcome
older -X- _ I-Outcome
children -X- _ I-Outcome
, -X- _ I-Outcome
respiratory -X- _ I-Outcome
picornaviruses -X- _ I-Outcome
dominated -X- _ I-Outcome
( -X- _ I-Outcome
65 -X- _ I-Outcome
% -X- _ I-Outcome
of -X- _ I-Outcome
children -X- _ I-Outcome
ages -X- _ I-Outcome
1-2 -X- _ I-Outcome
years -X- _ I-Outcome
and -X- _ I-Outcome
82 -X- _ I-Outcome
% -X- _ I-Outcome
of -X- _ I-Outcome
children -X- _ I-Outcome
ages -X- _ I-Outcome
> -X- _ I-Outcome
3 -X- _ I-Outcome
years -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
Human -X- _ I-Outcome
metapneumovirus -X- _ I-Outcome
was -X- _ I-Outcome
detected -X- _ I-Outcome
in -X- _ I-Outcome
4 -X- _ I-Outcome
% -X- _ I-Outcome
of -X- _ I-Outcome
all -X- _ I-Outcome
children -X- _ I-Outcome
and -X- _ I-Outcome
in -X- _ I-Outcome
11 -X- _ I-Outcome
% -X- _ I-Outcome
of -X- _ I-Outcome
infants. -X- _ I-Outcome
To -X- _ O
prevent -X- _ O
and -X- _ O
treat -X- _ O
acute -X- _ B-Patient
expiratory -X- _ I-Patient
wheezing -X- _ I-Patient
illnesses -X- _ I-Patient
in -X- _ I-Patient
children -X- _ I-Patient
, -X- _ O
efforts -X- _ O
should -X- _ O
be -X- _ O
focused -X- _ O
on -X- _ O
RSV -X- _ B-Outcome
, -X- _ I-Outcome
enterovirus -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
rhinovirus -X- _ I-Outcome
infections -X- _ I-Outcome
. -X- _ O

